174 related articles for article (PubMed ID: 22697263)
21. New guideline on treatment of idiopathic pulmonary fibrosis.
Spagnolo P; Bonella F; Maher TM
Lancet Respir Med; 2015 Sep; 3(9):e31-e32. PubMed ID: 26380887
[No Abstract] [Full Text] [Related]
22. [The Latest Information on Respiratory Disease Management. Topics: III. New Treatment of Idiopathic Pulmonary Fibrosis].
Kashiwada T; Azuma A
Nihon Naika Gakkai Zasshi; 2016 Jun; 105(6):970-6. PubMed ID: 30168687
[No Abstract] [Full Text] [Related]
23. Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.
Selvaggio AS; Noble PW
Annu Rev Med; 2016; 67():487-95. PubMed ID: 26565677
[TBL] [Abstract][Full Text] [Related]
24. [Patient treated with pirfenidone].
Valenzuela C
Arch Bronconeumol; 2012 Oct; 48 Suppl 2():19-20. PubMed ID: 23630973
[No Abstract] [Full Text] [Related]
25. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
Fiddler CA; Simler N; Parfrey H; Miremadi A; Chilvers ER
Ann Am Thorac Soc; 2016 Aug; 13(8):1430-2. PubMed ID: 27509160
[No Abstract] [Full Text] [Related]
26. [Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
Tokura T; Oku H; Tsukamoto Y
Nihon Yakurigaku Zasshi; 2009 Aug; 134(2):97-104. PubMed ID: 19672005
[No Abstract] [Full Text] [Related]
27. Is pirfenidone effective for idiopathic pulmonary fibrosis?
Jeldres A; Labarca G
Medwave; 2017 Jan; 17(Suppl1):e6843. PubMed ID: 28112713
[TBL] [Abstract][Full Text] [Related]
28. [Antifibrotic treatment].
von der Beck D; Löh B; Drakopanagiotakis F; Markart P; Günther A
Dtsch Med Wochenschr; 2014 Dec; 139(49):2523-5. PubMed ID: 25423462
[No Abstract] [Full Text] [Related]
29. COUNTERPOINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? No.
Brown KK
Chest; 2016 Aug; 150(2):276-8. PubMed ID: 27292046
[No Abstract] [Full Text] [Related]
30. Pirfenidone should be prescribed for patients with idiopathic pulmonary fibrosis.
Jenkins G
Thorax; 2013 Jul; 68(7):603-5. PubMed ID: 23462153
[No Abstract] [Full Text] [Related]
31. POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? Yes.
King CS; Nathan SD
Chest; 2016 Aug; 150(2):273-5. PubMed ID: 27292047
[No Abstract] [Full Text] [Related]
32. Pirfenidone: a novel agent for the treatment of idiopathic pulmonary fibrosis.
Potts J; Yogaratnam D
Ann Pharmacother; 2013 Mar; 47(3):361-7. PubMed ID: 23404802
[TBL] [Abstract][Full Text] [Related]
33. Optimal treatment for idiopathic pulmonary fibrosis.
Maher TM; Wells AU
Thorax; 2008 Dec; 63(12):1120-1; author reply 1121. PubMed ID: 19020278
[No Abstract] [Full Text] [Related]
34. Idiopathic pulmonary fibrosis.
Dempsey OJ; Miller D
BMJ; 2013 Nov; 347():f6579. PubMed ID: 24201334
[No Abstract] [Full Text] [Related]
35. An Unusual Case of Hypoxemia Improving Overnight in Idiopathic Pulmonary Fibrosis.
Carlucci A; Ceriana P; Micheletti A; Schreiber A; Butera G
J Cardiothorac Vasc Anesth; 2015 Oct; 29(5):e64-6. PubMed ID: 26119407
[No Abstract] [Full Text] [Related]
36. [Idiopathic pulmonary fibrosis -- progress in sight].
Kaarteenaho R; Hodgson U; Myllärniemi M
Duodecim; 2011; 127(24):2639-45. PubMed ID: 22320106
[TBL] [Abstract][Full Text] [Related]
37. Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis.
Glassberg MK; Wijsenbeek MS; Gilberg F; Petzinger U; Kirchgaessler KU; Albera C
Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31164431
[TBL] [Abstract][Full Text] [Related]
38. Idiopathic pulmonary fibrosis: recent milestones in disease management.
Costabel U
Eur Respir Rev; 2012 Jun; 21(124):140. PubMed ID: 22654085
[No Abstract] [Full Text] [Related]
39. Clinical trial research in focus: why do so many clinical trials fail in IPF?
Spagnolo P; Maher TM
Lancet Respir Med; 2017 May; 5(5):372-374. PubMed ID: 28412184
[No Abstract] [Full Text] [Related]
40. Real world experiences: pirfenidone is well tolerated in patients with idiopathic pulmonary fibrosis.
Chaudhuri N; Duck A; Frank R; Holme J; Leonard C
Respir Med; 2014 Jan; 108(1):224-6. PubMed ID: 24269005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
